返回排名列表

Centene Corp (CNC)

被低估
HealthcareHealthcare PlansUnited States

基本面

44

价格

$59.65

市值

$30.89B

第一部分 · 这家公司值多少

概览

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 2026年9月18日 with claude-haiku-4-5 — shared with all users

P/E: 15.7Score: 69Market cap: $85.57B

Elevance is the second-largest Medicaid managed care operator after Centene and also sells marketplace plans under its Anthem brands, so the two compete for the same state contracts and the same individual enrollees.

P/E: 23.6Score: 70Market cap: $336.61B

UnitedHealth's community and state business is one of the Big Five Medicaid plans and it has the widest ACA marketplace footprint of any insurer, overlapping Centene's Medicaid and Ambetter lines in most states.

P/E: 22.6Score: 58Market cap: $112.36B

Through Aetna, CVS Health is one of the five largest Medicaid managed care companies and a direct rival in Medicare Advantage and dual-eligible plans, the same government-funded members Centene serves.

P/E: 40.7Score: 62Market cap: $46.78B

Humana competes with Centene's Wellcare brand for Medicare Advantage and Part D members and bids for the same state Medicaid contracts, though it is far more concentrated on seniors.

Molina Healthcare, Inc.MOH

Molina is Centene's closest business twin: both build their revenue on state Medicaid contracts and ACA marketplace plans for low-income members, and they bid against each other in the same state procurements.

Oscar Health, Inc.OSCR

Oscar sells almost exclusively ACA marketplace plans in twenty states and is the main challenger to Ambetter, Centene's individual-exchange brand.

资产负债表与流动性

营收

$178.66B

最近12个月(截至2026/6/30)

净利润

$-5.10B

最近12个月(截至2026/6/30)

自由现金流

$4.32B

股东权益合计

$19.95B

负债合计

$56.69B

流动比率

1.15

利息覆盖率

8.61

债务/EBITDA

-

每股收益

营收与净利润

自由现金流

收入构成

历史财务表

利润率变化

债务变化

债务负担有多重

增长一览表

增长 — 营业收入

公允价值估算

一般情形被低估

公允价值

$152.99

当前价格

$59.65

安全边际

+61.0%

公允价值区间

$99.44 - $206.54

所用估值方法之间的离散区间,并非经过统计校准的置信区间。

估算方法

分析师目标价:$71.78
现金流折现法(DCF):$254.50
市盈率法(P/E):数据不足,无法计算
格雷厄姆成长公式:数据不足,无法计算
盈利能力价值(EPV):数据不足,无法计算
合理市净率(P/B):数据不足,无法计算
股息折现模型(戈登模型):数据不足,无法计算
P/FFO(运营资金):数据不足,无法计算
周期中段收益:$185.56
市销率法(P/S):$1574.88
分析师共识:买入 (12B / 14H / 1S)
最近财报超预期:+129.04%

估值指标

市盈率(P/E)

-

ROE

-33.4%

市净率(P/B)

1.36

P/FCF

3.43

毛利率

9.1%

ROIC

-10.5%

盈利能力雷达图

价值创造(经济护城河)

ROIC

-10.5%

WACC

8.0%

ROIC − WACC

-18.6 pp

ROIC 低于资本成本:公司每投入一美元都在毁灭价值。

基本面分析标准

通过(11)

  • Price CAGR 8.92%
  • P/FCF 3.43
  • P/B Ratio 1.36
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Revenue Growth 5Y 24.5%
  • Earnings Surprise avg 161.0%
  • Share Dilution -5.8%

未通过(11)

  • EPS shows upward trend
  • ROIC -10.5%
  • Gross Margin 9.1%
  • Operating Margin -3.2%
  • Return on Tangible Assets
  • Low reliance on intangibles
  • DCF valuation (Fairly valued)
  • ROE -24.0%
  • Analyst Consensus 44% Buy
  • Net Margin Trend -2.9% vs 1.3%
  • Piotroski F-Score 4/9

不可用(5)

  • Dividend Payout NaN%
  • Debt/EBITDA
  • Price below Graham Number
  • PEG Ratio (need PE > 0 and growth > 0)
  • Earnings Quality (OCF/Net Income)

Piotroski F-评分

4/9

信号混杂:部分领域需关注

score
criteria

盈利质量

-

低质量:需深入审查会计处理

股权稀释

-5.8%

正在回购股份,对股东友好

机构持股

公司治理

管理团队

姓名职位年龄
Ms. Sarah M. LondonCEO & Director44
Mr. Andrew Lynn AsherExecutive VP & CFO56
Ms. Susan R. SmithChief Operating Officer49
Mr. Christopher Andrew KosterExecutive VP, General Counsel & Secretary60
Ms. Tanya M. McNallySenior VP & Chief People Officer51
Mr. Theodore Joseph PienkosCorporate Controller & Chief Accounting Officer43
Mr. Bradley BolivarChief Information Officer-
Ms. Jennifer Lynch GilliganSenior Vice President of Investor Relations-
Ms. Ashlee KnuckeyChief Risk, Ethics & Compliance Officer-
Ms. Cary D. HobbsExecutive VP & Chief of Staff57

审计风险

2

董事会风险

2

薪酬风险

5

股东权利风险

1

第二部分 · 价格与买入时机

这一部分不判断公司是否值得拥有:它帮助你在基本面说服你之后,选择何时买入。包含:技术分析、潜力、历史回撤、Gamma 敞口。

文件

  • 年度报告(10-K)

    对公司业务、财务业绩和风险的年度概述。

    提交日期:2026-02-17

    查看文件
  • 季度报告(10-Q)

    最近三个月财务表现的最新情况。

    提交日期:2026-07-28

    查看文件
  • 临时报告(8-K)

    关于重大事件(如管理层变动或重要公告)的通知。

    提交日期:2026-09-16

    查看文件

via SEC EDGAR

损益历史

via SEC EDGAR

Latest News

Recent headlines for CNC, sourced from Markets Gazette.

  • 7/28/2026POSITIVE
    Centene Boosts Guidance, Reports Favorable Medical Costs

    Centene Corporation has raised its annual profit guidance, signaling strong performance in the second quarter. The health insurer's improved outlook comes amid expectations that it can successfully navigate evolving government policies impacting the sector. This upward revision suggests robust operational execution and potentially better-than-anticipated medical cost management, which are key drivers for profitability in the health insurance industry. Investors will likely view this as a positive indicator of the company's resilience and future earnings potential.

  • 6/18/2026NEUTRAL
    If You Invested $100 In Centene Stock 20 Years Ago, You Would Have This Much Today

    An investment of $100 in Centene Corporation (CNC) stock twenty years ago would have yielded a significant return, though the exact figure is not provided in this summary. The article likely details the historical performance of Centene, a major managed care organization, over the past two decades. Investors considering Centene should analyze its long-term growth trajectory, market position within the healthcare sector, and any significant strategic shifts or regulatory challenges it has faced during this period to understand the drivers of its past performance and future potential.

  • 6/16/2026NEGATIVE
    Membership Slump Forces Health Giant Centene Into Staff Buyouts: Report

    Centene Corporation is implementing a significant cost-cutting initiative, offering voluntary buyouts to employees due to a notable decline in health plan enrollment. This move signals financial pressure and a strategic pivot to reduce operational expenses. Investors should monitor the effectiveness of these cost-saving measures and the company's ability to stabilize or grow its membership base in the coming quarters. The success of this plan will be crucial for future profitability and stock performance.

  • 3/25/2026NEUTRAL
    The youngest-ever female Fortune 500 CEO is reinventing the largest Medicaid insurer amid funding cuts and rising costs

    The article highlights the leadership of the youngest-ever female CEO at a Fortune 500 company, who is navigating Centene Corporation, a major Medicaid insurer, through a challenging environment of funding cuts and rising healthcare costs. While the article focuses on the CEO's strategic initiatives and the company's resilience, it does not provide specific financial performance data or forward-looking guidance that would directly impact stock valuation. Investors will be watching for how these strategies translate into tangible financial results in upcoming quarters.

  • 3/15/2026NEGATIVE
    Centene, Paramount Skydance, And Ulta Beauty Are Among Top 10 Large Cap Losers Last Week (March 9-March 13): Are the Others in Your Portfolio?

    Centene Corporation was among the top 10 large-cap decliners last week, with its stock price falling significantly. The broader market saw healthcare, media, beauty, and tech stocks leading the downturn. This decline was attributed to a combination of factors including earnings misses, weak forward-looking guidance provided by companies, downward analyst revisions, and challenging financing conditions. Investors are advised to monitor these headwinds closely as they impact sentiment and stock performance across various sectors.

  • 3/10/2026NEGATIVE
    Obamacare enrollment is plunging as costs soar, pushing down stocks like Centene

    Centene Corporation's stock is facing pressure as enrollment in the Affordable Care Act (ACA), also known as Obamacare, plummets. Soaring costs associated with the ACA are making health insurance plans less attractive, leading to a decline in policyholders. This trend directly impacts health insurers like Centene, which derive a significant portion of their revenue from ACA-compliant plans. The decrease in enrollment suggests lower premium revenues and potentially higher per-member costs for insurers, signaling a challenging financial outlook for the company and potentially others in the managed care sector.

via Markets Gazette